Pharmafile Logo
Pharmafocus logo
Advanced Search
janssen_latest_logo_on_sign_closer

Janssen seals global inherited retinal disease partnership with gene therapy firm MeiraGTx

February 1, 2019
Medical Communications, Research and Development, Sales and Marketing Janssen, MeiraGTx, eye care, gene therapy, pharma

In a bid to boost its portfolio in the eye care space, Janssen has announced a global partnership with clinical-stage …

News
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

February 1, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, England, NHS, Purdue, Vertex, insys, israel, oncology, pharma, top 10

Scandal dominated this week’s news after Sunrise Lee, a stripper turned Insys sales rep was alleged to have given a …

News
washington_state

Health officials declare state of emergency in Washington after 36 confirmed cases of measles

February 1, 2019
Medical Communications MMR, Seattle, measles, oregon, portland, vaccines, washington

Health officials have declared a state of emergency in Washington as an outbreak of measles continues to spread. As January …

News
kymriah

Novartis’ CAR-T therapy Kymriah gets NICE green light in diffuse large B-cell lymphoma

February 1, 2019
Medical Communications, Sales and Marketing CAR-T, Cancer, Kymriah, NICE, Novartis, lymphoma, pharma

NICE has announced another momentous decision for lymphoma patients in England and Wales:, recommending Novartis’ chimeric antigen receptor T cell …

News

400 Pfizer employees set to strike over pensions

February 1, 2019
Medical Communications EU, Ireland, Little Island, Pfizer, Ringaskiddy, SITPU, strike

400 Pfizer employees are set to go on strike in Ireland over an ongoing pensions dispute. Members of SITPU, Ireland’s …

News
both_together

Repurposed drugs: The Supreme Court deals a blow to patentees

January 31, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Supreme Court, drug repurposing, feature, patents, pharma

Second medical use patents protect the discovery that an existing drug is effective to treat a new condition. But, following …

Feature

Stripper-turned-Insys sales rep gave lap dance to persuade doctor to prescribe fentanyl

January 31, 2019
Medical Communications Sunrise Lee, US, chicago, corruption, insys, sales

A pharmaceutical executive working for Insys therapeutics has been accused of giving a doctor a lap dance in an effort …

News
janssen_latest_logo_on_sign

Janssen’s Erleada meets primary endpoints in ongoing trial into metastatic castration-sensitive prostate cancer

January 31, 2019
Research and Development Cancer, Erleada, Janssen, pharma, prostate cancer

Janssen has revealed that its androgen receptor (AR) inhibitor Erleada (apalutamide), in combination with androgen deprivation therapy (ADT), has been …

News
mylan_building

Mylan’s Wixela becomes first FDA-approved generic version of GSK’s Advair inhaler

January 31, 2019
Sales and Marketing Advair, COPD, FDA, Wixela, asthma, generic, pharma

Mylan’s Wixela has become the first generic version of GlaxoSmithKline’s Advair Diskus (fluticasone propionate and salmeterol inhalation powder) inhaler to …

News
920x920

Purdue Pharma sought to expand into opioid addiction treatments while using McKinsey to counter “emotional messages”

January 31, 2019
Business Services, Medical Communications Massachusetts, OxyContin, Purdue Pharma, US, USA, opioids

OxyContin drugmaker Purdue Pharma explored expanding into the market for opioid addiction treatments, according to passages from court documents that …

News
6813384933_1fb31d73fb_z

Health Secretary pledges to end transmission of HIV in England by 2030

January 31, 2019
Medical Communications, Research and Development 2030, AIDS, England, HIV, UN, health

Through better prevention, detection and treatment, Health Secretary Matt Hancock has pledged to end transmission of HIV in England by …

News
richard_ridinger

Richard Ridinger resigns from CEO position at Lonza causing shares to plummet

January 30, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CEO, Lonza, Marc Funk, Richard Ridinger, Switzerland

Richard Ridinger, the CEO of Swiss biotechnology firm Lonza Group, will step down from his position in March of this …

Appointment
pharmafocus_janfeb_2019_cover

Read Pharmafocus January/February 2019 edition online now!

January 30, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, Cancer, Counterfeit drugs, NHS, Pharmafocus, WHO, brexit, pharma, vaccines

We’re slowly edging towards warmer months, but the New Year brings more than just the promise of more amicable weather; …

News
takeda_usa_pharmaceuticals_u

Takeda’s dengue vaccine proves efficacious in massive Phase 3 trial

January 30, 2019
Research and Development Dengue fever, TAK-003, Takeda, Vaccine, dengue, health, infectious diseases

Takeda’s dengue vaccine candidate TAK-003, has proved efficacious in preventing dengue fever in healthy children and adolescents in an ongoing …

News
cancer-cells-541954_960_720

Israeli biotech claims it has developed cure for cancer

January 30, 2019
Research and Development Cancer, MuTaTo, biotech, israel, lung cancer, oncology

An Israeli biotech has claimed that it has developed a complete cure for cancer. Speaking to the Jerusalem Post, Dan …

News
shutterstock_38078521

Roche pulls plug on Alzheimer’s drug after Phase 3 failure

January 30, 2019
Research and Development AC Immune, Alzheimer's, Roche, crenezumab, pharma

Roche has announced that it is to terminate two Phase 3 studies investigating the efficacy of its anti-beta-amyloid molecule crenezumab …

News

ABPI warns of skills shortage in UK caused by lack of STEM grads and Brexit

January 30, 2019
Research and Development ABPI, UK, eomployment, skills, stem, work

The UK is falling behind Europe and the rest of the world in regards to the number of students studying …

News
920x920

Opioid drugmaker Purdue Pharma inks deal with Alivio over non-opioid inflammation drug

January 29, 2019
Manufacturing and Production Alivio, Purdue Pharma, health, inflammation, opioids

Opioid drugmaker Purdue Pharma has entered into an agreement with inflammatory disease specialist Alivio Therapeutics for the development of the …

News

Imbruvica combo scores expanded FDA approval in most common adult form of leukaemia

January 29, 2019
Manufacturing and Production, Sales and Marketing AbbVie, Cancer, Janssen, imbruvica, leukaemia, pharma

It’s big news for Janssen and AbbVie as it emerged that their jointly-developed Bruton’s tyrosine kinase (BTK) inhibitor Imbruvica (ibrutinib) …

News
800px-t_lymphocyte_16760076824

Precision cancer treatment for dogs moves towards human testing

January 29, 2019
Manufacturing and Production CAR-T therapy, Cancer, Precision Medicine, car t therapy, dogs, t cells, t-cells

Scientists at the University of Missouri have developed a patient specific, precision medicine treatment for bone cancer in dogs. The …

News
The Gateway to Local Adoption Series

Latest content

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026

Rentschler Biopharma appoints Uwe Buecheler as interim CEO

January 26, 2026

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026